financetom
Business
financetom
/
Business
/
Why United Airlines (UAL) Stock Hit A New 52-Week High
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why United Airlines (UAL) Stock Hit A New 52-Week High
Oct 18, 2024 8:58 AM

United Airlines shares hit a new 52-week high of $74.56 this week. The company's third-quarter earnings report were released Tuesday after the market closed.United Airlines Holdings Inc ( UAL ) shares hit a new 52-week high of $74.56 this week following the company’s third-quarter earnings report released Tuesday after the market closed.

What Happened: The Chicago-headquartered airline reported revenue of $14.843 billion, exceeding the consensus estimate of $14.783 billion, while adjusted earnings per share reached $3.33, surpassing analyst predictions of $3.13.

UAL’s capacity grew by 4.1% year-over-year, indicating an expansion in service expected to bolster future revenue. Despite a slight decrease in total revenue per available seat mile (TRASM) of 1.6%, operating cash flow remained strong at $7.2 billion, with free cash flow totaling $3.4 billion year-to-date.

This fiscal strength is further emphasized by United's liquidity position of $17.1 billion, although it carries $25.7 billion in total debt and finance lease obligations.

Read Also: American Express Q3 Earnings: Profit Beats Estimate, Card Spending Grows, Revises Annual Outlook

CEO Scott Kirby noted that the removal of unproductive capacity from the market in mid-August led to a notable improvement in revenue trends, allowing United to exceed third-quarter expectations.

His comments reflect a positive outlook for the airline, highlighting a strategy focused on enhancing customer experience through initiatives like United Next.

What Else: In a move that signals confidence in its financial trajectory, United's board approved a new share repurchase program worth up to $1.5 billion, which could potentially bolster stock performance by reducing the number of shares outstanding.

However, the airline's outlook for the fourth quarter suggests a slight pullback in adjusted earnings expectations, projecting earnings per share between $2.50 and $3, compared to analyst estimates of $3.17.

Overall, the strong financial results and strategic initiatives are likely to positively influence United Airlines’ stock performance, continuing the bullish momentum it has experienced throughout the year, with a reported gain of 56% so far.

As investors react to the earnings report, the market will closely monitor United's capacity management and customer experience enhancements, which are essential for sustaining its competitive position in the airline industry.

Read Also: Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season

How To Buy UAL Stock

By now you're likely curious about how to participate in the market for United Airlines Holdings ( UAL ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of United Airlines Holdings ( UAL ), which is trading at $73.33 as of publishing time, $100 would buy you 1.36 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, UAL has a 52-week high of $74.56 and a 52-week low of $33.68.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mitek Systems Fiscal Q4 Non-GAAP Earnings, Revenue Increase -- Share Surge After Hours
Mitek Systems Fiscal Q4 Non-GAAP Earnings, Revenue Increase -- Share Surge After Hours
Dec 16, 2024
04:41 PM EST, 12/16/2024 (MT Newswires) -- Mitek Systems ( MITK ) reported fiscal Q4 non-GAAP earnings late Monday of $0.33 per diluted share, up from $0.15 a year earlier. Analysts polled by FactSet expected $0.17. Revenue for the quarter that ended Sept. 30 was $43.2 million, up from $37.7 million a year earlier. Analysts surveyed by FactSet expected $41.3...
Ul Solutions Insider Sold Shares Worth $1,074,039, According to a Recent SEC Filing
Ul Solutions Insider Sold Shares Worth $1,074,039, According to a Recent SEC Filing
Dec 16, 2024
04:42 PM EST, 12/16/2024 (MT Newswires) -- Gitte Schjotz, Executive Vice President & Chief Science and Operations Officer, on December 12, 2024, sold 21,000 shares in Ul Solutions ( ULS ) for $1,074,039. Following the Form 4 filing with the SEC, Schjotz has control over a total of 45,273 shares of the company, with 45,273 shares held directly. SEC Filing:...
Becton Dickinson settles charges over infusion pump risks, SEC says
Becton Dickinson settles charges over infusion pump risks, SEC says
Dec 16, 2024
WASHINGTON, Dec 16 (Reuters) - The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. ( BDX ) over allegations it misled investors about risks associated with its Alaris infusion pump. The SEC said Becton Dickinson ( BDX ) agreed to pay a $175 million civil penalty to settle the charges,...
Jazz Pharmaceuticals CEO Bruce Cozadd Plans to Retire
Jazz Pharmaceuticals CEO Bruce Cozadd Plans to Retire
Dec 16, 2024
04:42 PM EST, 12/16/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Monday it that Co-founder, Chairperson and Chief Executive Bruce Cozadd plans to retire. Cozadd will retire as CEO upon the appointment of his replacement, which is expected by the end of 2025, but will continue as chairperson of the board, according to the company. The company said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved